Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/SCPHARMACEUTICALS INC/ 10-K

Annual Report · 10-K

SCPHARMACEUTICALS INC

Annual Report

Filed Mar 19, 2025Accepted Mar 19, 2025, 1:20 PM EDTCIK 1604950Accession 0000950170-25-042159
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
SCPHNASDAQ · EQUITY · Historical · closed Oct 6, 2025

Recent company filings

  1. SCHEDULE 13G/A - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Feb 11, 2026
  2. EFFECT filingNov 19, 2025
  3. EFFECT filingNov 19, 2025
  4. EFFECT filingNov 19, 2025
  5. SCHEDULE 13G - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Nov 12, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗